365 related articles for article (PubMed ID: 16310381)
21. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b(5) reductase gene leading to methemoglobinemia type I.
Dekker J; Eppink MH; van Zwieten R; de Rijk T; Remacha AF; Law LK; Li AM; Cheung KL; van Berkel WJ; Roos D
Blood; 2001 Feb; 97(4):1106-14. PubMed ID: 11159544
[TBL] [Abstract][Full Text] [Related]
22. Clinical spectrum and molecular basis of recessive congenital methemoglobinemia in India.
Warang PP; Kedar PS; Shanmukaiah C; Ghosh K; Colah RB
Clin Genet; 2015; 87(1):62-7. PubMed ID: 24266649
[TBL] [Abstract][Full Text] [Related]
23. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
Davis CA; Dhawan IK; Johnson MK; Barber MJ
Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and biological forms of cytochrome b5 reductase deficiency].
Kaplan JC; Leroux A; Beauvais P
C R Seances Soc Biol Fil; 1979; 173(2):368-79. PubMed ID: 159760
[TBL] [Abstract][Full Text] [Related]
25. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis.
Aalfs CM; Salieb-Beugelaar GB; Wanders RJ; Mannens MM; Wijburg FA
Hum Mutat; 2000; 16(1):18-22. PubMed ID: 10874300
[TBL] [Abstract][Full Text] [Related]
26. Novel mutation (R192C) in CYB5R3 gene causing NADH-cytochrome b5 reductase deficiency in eight Indian patients associated with autosomal recessive congenital methemoglobinemia type-I.
Kedar PS; Gupta V; Warang P; Chiddarwar A; Madkaikar M
Hematology; 2018 Sep; 23(8):567-573. PubMed ID: 29482478
[TBL] [Abstract][Full Text] [Related]
27. Assimilatory nitrate reductase: lysine 741 participates in pyridine nucleotide binding via charge complementarity.
Barber MJ; Desai SK; Marohnic CC
Arch Biochem Biophys; 2001 Oct; 394(1):99-110. PubMed ID: 11566032
[TBL] [Abstract][Full Text] [Related]
28. Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum.
Ewenczyk C; Leroux A; Roubergue A; Laugel V; Afenjar A; Saudubray JM; Beauvais P; Billette de Villemeur T; Vidailhet M; Roze E
Brain; 2008 Mar; 131(Pt 3):760-1. PubMed ID: 18202104
[TBL] [Abstract][Full Text] [Related]
29. Enzymopenic hereditary methemoglobinemia: a clinical/biochemical classification.
Jaffé ER
Blood Cells; 1986; 12(1):81-90. PubMed ID: 3539237
[TBL] [Abstract][Full Text] [Related]
30. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II.
Vieira LM; Kaplan JC; Kahn A; Leroux A
Blood; 1995 Apr; 85(8):2254-62. PubMed ID: 7718898
[TBL] [Abstract][Full Text] [Related]
31. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase.
Marohnic CC; Bewley MC; Barber MJ
Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867
[TBL] [Abstract][Full Text] [Related]
32. Arginine 91 is not essential for flavin incorporation in hepatic cytochrome b(5) reductase.
Marohnic CC; Barber MJ
Arch Biochem Biophys; 2001 May; 389(2):223-33. PubMed ID: 11339812
[TBL] [Abstract][Full Text] [Related]
33. Structural and mechanistic roles of three consecutive Pro residues of porcine NADH-cytochrome b(5) reductase for the binding of beta-NADH.
Nishimura Y; Shibuya M; Muraki A; Takeuchi F; Park SY; Tsubaki M
J Biosci Bioeng; 2009 Oct; 108(4):286-92. PubMed ID: 19716516
[TBL] [Abstract][Full Text] [Related]
34. [Leu 72 Pro mutation in the NADH-cytochrome b5 reductase gene found in a Chinese hereditary methemoglobinemia patient].
Wu Y; Huang C; Zhu Z
Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):195-7. PubMed ID: 11243135
[TBL] [Abstract][Full Text] [Related]
35. Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: compound heterozygous for NADH-cytochrome b5 reductase gene mutations.
Kedar PS; Warang P; Ghosh K; Colah RB
Am J Hematol; 2011 Mar; 86(3):327-9. PubMed ID: 21328435
[No Abstract] [Full Text] [Related]
36. Congenital methaemoglobinaemia Type I in a Turkish infant due to a novel mutation, Pro144Ser, in NADH-cytochrome b5 reductase.
Percy MJ; Oren H; Savage G; Irken G
Hematol J; 2004; 5(4):367-70. PubMed ID: 15297856
[TBL] [Abstract][Full Text] [Related]
37. Recessive congenital methemoglobinemia caused by a rare mechanism: maternal uniparental heterodisomy with segmental isodisomy of a chromosome 22.
Huang YH; Tai CL; Lu YH; Wu TJ; Chen HD; Niu DM
Blood Cells Mol Dis; 2012 Aug; 49(2):114-7. PubMed ID: 22658170
[TBL] [Abstract][Full Text] [Related]
38. Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase Gene.
Forestier A; Pissard S; Cretet J; Mambie A; Pascal L; Cliquennois M; Cambier N; Rose C
Hemoglobin; 2015; 39(6):438-41. PubMed ID: 26291966
[TBL] [Abstract][Full Text] [Related]
39. Mutation update: Variants of the CYB5R3 gene in recessive congenital methemoglobinemia.
Gupta V; Kulkarni A; Warang P; Devendra R; Chiddarwar A; Kedar P
Hum Mutat; 2020 Apr; 41(4):737-748. PubMed ID: 31898843
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis of two novel mutations found in type I methemoglobinemia.
Lorenzo FR; Phillips JD; Nussenzveig R; Lingam B; Koul PA; Schrier SL; Prchal JT
Blood Cells Mol Dis; 2011 Apr; 46(4):277-81. PubMed ID: 21349748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
